That is my point no profits yet the Stock has gone sky high, Sativex is a watered down product. When the masses find out about this they will want a more potent product.
Companies like Endocan will have products that will be cheaper cost wise and more potent when they rollout products soon.
also did not know about this about GW agreements.
"Our partners have the right, under certain
circumstances, to terminate their agreements with us, and three of our partners, Almirall, Otsuka and
Novartis, have the right to terminate their agreements with us without cause. A failure by our partners
to successfully market Sativex, or the termination of agreements with our partners, will have a material
adverse effect on our business, results of operations and financial condition. "